Aspen One wants to “stay in business forever.” To do that, the parent company of Aspen Skiing Co., Aspen Hospitality and Aspen Collection needs employees, and those employees need somewhere to live.

In recent years, EDR killers have become one of the most commonly seen tools in modern ransomware intrusions: an attacker acquires high privileges, deploys such a tool to disrupt protection, and only ...

View post: Work Continues on New Mexico's First High-Speed Six-Seater Lift According to a plan submitted late last year, several new lifts may be coming to Aspen Highlands, Colorado, and to the ...

From June 19 to 21, more than 60 chefs and drinks experts — including Bobby Flay, Andrew Zimmern, Mark Oldman, and Lynette Marrero — will lead demos, tastings, and seminars across Aspen. Stacey Leasca ...

Cyberattacks are not always obvious, but their effects become evident when systems become slow, data is lost, or operations halt. Moreover, endpoints are common points of attack when employees work on ...

A new malware campaign targeting human resources and recruiting staff has seen attackers distribute malicious files disguised as job applications. The operation, uncovered by Aryaka Threat Research ...

Russian-speaking threat actors are targeting human resources (HR) workflows with an attack campaign that conceals a malicious tool within steganographic image files, which can bust enterprise ...

Aspen City Council on Tuesday approved an electrification study that will analyze the effect of electrification on the Aspen Electric Grid. The city plans to allot $132,175 to the study from its ...

After more than a decade of planning, an overlooked side of the ski haven of Aspen, Colorado, will soon be revamped into a new base village. Named Chalet Alpina and covering two-and-a-half city blocks ...

Hackers are abusing a legitimate but long-revoked EnCase kernel driver in an EDR killer that can detect 59 security tools in attempts to deactivate them. An EDR killer is a malicious tool created ...

Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ongoing trial of a regenerative cell therapy for Parkinson’s disease. The ...